Global Cord Blood (NYSE:CO) Shares Pass Above 200-Day Moving Average - Should You Sell?

Key Points

• Global Cord Blood's stock price crossed above its 200-day moving average during trading, reaching a high of $1.40 and last trading at $1.40, indicating positive momentum.
• Wall Street Zen has initiated coverage on the company with a "strong-buy" rating, suggesting strong confidence in its future performance.
• The company has a current market cap of $170.17 million and a price-to-earnings ratio of 2.19, reflecting its valuation metrics.

Shares of Global Cord Blood Co. (NYSE:CO - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.98 and traded as high as $1.40. Global Cord Blood shares last traded at $1.40, with a volume of 11,665 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen assumed coverage on Global Cord Blood in a research note on Saturday, May 17th. They issued a "strong-buy" rating on the stock.

Global Cord Blood Price Performance

The stock has a market capitalization of $188.40 million, a PE ratio of 2.42 and a beta of 0.16. The stock has a 50 day moving average of $1.01 and a two-hundred day moving average of $0.98.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.